<DOC>
	<DOCNO>NCT00002056</DOCNO>
	<brief_summary>This randomize double-blinded control study compare aerosolize pentamidine trimethoprim plus sulfamethoxazole ( TMP / PurposeX ) . The latter drug administer intravenously least 5 day , change oral administration warrant patient 's clinical condition .</brief_summary>
	<brief_title>A Controlled Trial Comparing Efficacy Aerosolized Pentamidine Parenteral / Oral Trimethoprim - Sulfamethoxazole Treatment Pneumocystis Carinii Pneumonia AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine long therapy suspend prior randomization reinstituted therapy acute episode complete . Pneumocystis carinii pneumonia ( PCP ) adult HIV positive ELISA , HIV culture , p24 antigenemia , member risk group HIV infection ( homosexual bisexual men , intravenous drug abuser , recipient HIV infect blood product , sexual partner forego group ) . The patient must rest Alveolar arterial oxygen ( Aa ) DO2 le 30 mmHg room air ACTG sit , except San Francisco General Hospital . Other site enter patient rest ( Aa ) DO2 = &lt; 55 mmHg room air . Prior Medication : Allowed : Zidovudine long therapy suspend prior randomization reinstituted therapy acute episode complete . Exclusion Criteria Coexisting Condition : Patients follow exclude : Dyspnea . Cough . Bronchospasm . History major adverse reaction pentamidine sulfonamide contain preparation . Patients follow exclude : Inability cooperate aerosol administration dyspnea , cough , bronchospasm , reason . History major adverse reaction pentamidine sulfonamide contain preparation . In opinion investigator , patient would complete therapy followup social reason . Prior Medication : Excluded within 14 day study entry : Systemic steroid adrenal replacement dos . Excluded within 6 week study entry : Other antiprotozoal regimen episode trimethoprim / sulfamethoxazole ( TMP / PurposeX ) . Pyrimethamine . Fansidar . Pentamidine . Eflornithine ( DFMO ) . Dapsone , whether therapeutic prophylactic , agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1989</verification_date>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Injections , Intravenous</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Aerosols</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>